Mark Wallace

Medical Advisor at Navega Therapeutics

Dr. Wallace is Chair, Division of Pain Medicine, Department of Anesthesiology, UCSD. He diagnoses and treats all forms of pain, with a focus on chronic pain. He has extensive experience with spinal drug delivery to treat chronic pain.


Org chart

This person is not in the org chart


Teams

This person is not in any teams


Offices

This person is not in any offices


Navega Therapeutics

Navega Therapeutics has developed a patented, non-permanent gene therapy to target pain that is non-addictive, highly specific, and long-lasting. Navega Therapeutics has imitated this process by utilizing a novel gene therapy to target pain in a non-permanent way.


Industries

Employees

1-10

Links